Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Arena Pharmaceuticals
Arena Pharmaceuticals
Industry · 17 registered clinical trials.
Status
Trial
Phase
Started
Terminated
Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
Irritable Bowel Syndrome
Phase 1
2021-01-29
Completed
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
2020-09-15
Completed
A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
Phase 2
2019-10-04
Terminated
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With P
Irritable Bowel Syndrome
Phase 2
2019-07-24
Completed
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
2019-06-13
Terminated
Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis
Phase 2
2017-12-29
Completed
Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdom
Crohn's Disease, Abdominal Pain
Phase 2
2017-07-19
Terminated
Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intest
Inflammatory Bowel Diseases, Skin Extra-intestinal Manifestations
Phase 2
2017-07-17
Terminated
Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 2
2017-06-07
Completed
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 2
2016-01-25
Completed
Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
Ulcerative Colitis
Phase 2
2015-10-15
Completed
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
Smoking Cessation
Phase 2
2014-03-01
Completed
Single-dose Safety Study of APD916 in Healthy Volunteers
Narcolepsy With or Without Cataplexy
Phase 1
2010-03-01
Completed
Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia
Primary Insomnia
Phase 2
2008-04-01
Completed
A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healt
Healthy
Phase 1
2008-01-01
Completed
Single-Dose Safety Study of APD791 in Healthy Volunteers
Healthy
Phase 1
2007-07-01
Completed
Safety and Efficacy Study of APD125 in Patient With Insomnia
Insomnia
Phase 2
2007-02-01